Cost-Utility Analysis of Dasatinib and Nilotinib in...

Clinical Therapeutics 2014 / 04 Vol. 36; Iss. 4

Cost-Utility Analysis of Dasatinib and Nilotinib in Patients With Chronic Myeloid Leukemia Refractory to First-Line Treatment With Imatinib in Thailand

Kulpeng, Wantanee, Sompitak, Sumalai, Jootar, Saengsuree, Chansung, Kanchana, Teerawattananon, Yot
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
36
Language:
english
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2014.02.008
Date:
April, 2014
File:
PDF, 433 KB
english, 2014
Conversion to is in progress
Conversion to is failed